| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.11.23 | Mineralys Therapeutics, Inc.: Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023 | 174 | GlobeNewswire (Europe) | - New analysis on serum leptin levels among patients in the Target-HTN Phase 2 trial adds to emerging evidence of positive feedback loop linking obesity, leptin and aldosterone - - Excess aldosterone... ► Artikel lesen | |
| 11.11.23 | Esperion Therapeutics, Inc.: Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 | 308 | GlobeNewswire (Europe) | - Data from Randomized Control Trial Will Advance Evidence for Evaluation and Treatment of Heart Disease by Studying Actual Disease: Atherosclerosis - ANN ARBOR, Mich., Nov. 11, 2023 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 11.11.23 | Long-term Survival Data from Longeveron's ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association | 197 | GlobeNewswire (Europe) | Extended Follow Up Data Show Continued, Transplant Free Survival of All Patients Results Support Continued Investigation of Lomecel-BTM As Adjunct to Stage II Surgery in HLHS - Enrollment ongoing... ► Artikel lesen | |
| 11.11.23 | Novo Nordisk A/S: Semaglutide 2.4 mg (Wegovy) cardiovascular outcomes data presented at American Heart Association Scientific Sessions and simultaneously published in New England Journal of Medicine | 192 | GlobeNewswire (Europe) | Semaglutide 2.4 mg delivered a statistically significant 20% risk reduction in major adverse cardiovascular events (MACE) with risk reductions demonstrated consistently across age, gender, ethnicity... ► Artikel lesen | |
| 11.11.23 | Apollo Strategic Growth Capital II Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination | 373 | GlobeNewswire (Europe) | NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Apollo Strategic Growth Capital II (NYSE: APGB) (the "Company"), a publicly-traded special purpose acquisition company, today announced that it will liquidate... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 610 |
| BAYER | 403 |
| BYD | 337 |
| NEL | 321 |
| NVIDIA | 295 |
| TESLA | 283 |
| DEUTSCHE BANK | 278 |
| TUI | 276 |
| PLUG POWER | 274 |
| SUPER MICRO COMPUTER | 255 |
| APPLE | 242 |
| RHEINMETALL | 235 |
| RWE | 228 |
| MERCEDES-BENZ | 212 |
| DEUTSCHE LUFTHANSA | 206 |
| AMAZON | 195 |
| BERKSHIRE HATHAWAY | 192 |
| RENK GROUP | 162 |
| VOLKSWAGEN | 160 |
| ALLIANZ | 158 |
| AIXTRON SE | 155 |
| COMMERZBANK | 155 |
| BIONTECH | 154 |
| PAYPAL | 151 |
| BASF | 149 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
